U₃O₈90.02-0.22%FUTURESmodeled
All critical minerals

Gadolinium supply chain

Gadolinium is the active ingredient in most MRI contrast agents and absorbs neutrons in nuclear reactors. It is also used in specialty alloys, coatings and electronics.

Gadolinium (Gd) · Rare earths · data as of

U.S. net import reliance

—

Not published for this mineral.

Top mining country

—

No country shares published.

Top processing country

—

No country shares published.

Top U.S. import source

—

No country split published.

Direct dependency

—

Needs a published reliance figure and an import split.

Where it is mined, processed and imported from

Each column is one stage, split by country share. Ribbons run through a neutral pool because the sources do not publish how much of one country’s output went to which processor. Import shares record the shipping country, not the origin, and material inside finished goods is not counted. A dashed outline marks a figure from a thinner source or one not rechecked. Select a country to follow it across the stages.

U.S. net import reliance: not published

No source publishes country shares for gadolinium on its own. This diagram is for all rare earths together. Figures specific to gadolinium are in the tables further down. Rare earths page

  • United States
  • Allies
  • China
  • Other restricted countries
  • Rest of world
  • Other, grouped

Mining

2025

Processing

separation/refining of magnet rare earths, 2024

  • China91%
  • Other countries9%

U.S. imports

rare-earth compounds and metals, 2021-2024

U.S. supply

net import reliance

  • Imported (net)67%
  • Domestic and stocks33%

Who has called it a bottleneck

Public statements by the military, agencies and manufacturers, paraphrased. Check the linked source before quoting one.

  • GE HealthCare

    Manufacturerexplicit

    Argus reported that GE HealthCare is running clinical trials of a manganese-based alternative to gadolinium MRI contrast agents and cites supply security as a key benefit, amid a Western gadolinium shortage. Reported by Argus, not a direct company filing.

    Source

The figures and their sources

Every row in the dataset for gadolinium, with its year and source. Real means the source publishes the figure. Estimated means the share was computed from published tonnages.

Mining

No figures published for this stage.

Processing and refining

No figures published for this stage.

U.S. imports

No figures published for this stage.

U.S. production and consumption

Domestic production
Not published.
Apparent consumption
Not published.

Confidence and notes on the figures

Medium: some figures are derived, come from secondary sources, or cover different years.

No public mine or refinery tonnage by country was found for this element alone, so the flow figures shown are those of the aggregate entry. China placed this element under export licensing in April 2025 and that control was still in force in December 2025 (USGS). Argus (Oct 2026) reported European gadolinium oxide at $2,500-3,000/kg, up about 708% since January 2026, with medical and defense buyers competing for licensed exports; it describes supply as largely dependent on Chinese mining and processing but gives no percentage. Bayer said its contrast-agent supply was unaffected. Lynas listed gadolinium among heavy rare earths it plans to separate in Malaysia. CRS classes gadolinium as a light rare earth; other sources group it with medium/heavy. The USGS risk category shown follows from the ranges the report gives.

Sources

Method, known gaps and file downloads are on the critical minerals overview. This page is informational and is not investment advice.

Cite this page

Using our data in an article or report? Please credit Yellowcake Analytics with a link.

Citation

Yellowcake Analytics. "Gadolinium Supply Chain." Yellowcake Analytics, 2026, https://www.yellowcakeanalytics.com/critical-minerals/gadolinium.

HTML (with link)

<a href="https://www.yellowcakeanalytics.com/critical-minerals/gadolinium">Gadolinium Supply Chain</a> — Yellowcake Analytics (www.yellowcakeanalytics.com)

The weekly uranium brief

Spot moves, SPUT flows, filings, and contract news, once a week. Plus a free daily CSV of our uranium equity screener snapshot.

Free forever. One email a week + a daily data CSV. By subscribing you agree to receive marketing email from Yellowcake Analytics (privacy policy). Unsubscribe anytime.